Global Acne Drugs Market 2016-2020

ニキビ治療薬の世界市場2016-2020

◆タイトル:Global Acne Drugs Market 2016-2020
◆商品コード:IRTNTR7887
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年11月18日
◆ページ数:84
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、ニキビ治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、ニキビ治療薬の世界市場規模及び予測、種類別分析、製品別分析、投与経路(ROA)別分析、市場シェア、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、医療費償還シナリオ、製品パイプライン分析、市場動向、競争状況などの情報をお届けいたします。

Covering: This market research report presents a detailed segmentation of the global acne drugs market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and by type (prescription and OTC). It outlines the market shares for key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Allergan, Galderma, Stiefel, and Valeant.

Technavios market research analyst predicts the global acne drugs market to grow steadily at a CAGR of approximately 3% during the forecast period. The occurrence of acne due to lifestyle changes is the primary driver for the market. Sedentary lifestyle and unhealthy food habits lead to hormonal problems, which trigger the development of acne. Lack of sleep, emotional and work-related stress, smoking, drug abuse, and alcohol consumption are major triggers for the occurrence of acne among teenagers and adults.

The rise in disposable income has encouraged consumers, especially the middle-class income group, to spend more on personal care products. The rising awareness of acne and the current and upcoming treatments is expected to drive the acne drugs market through the forecast period. Women particularly, play a crucial role in this market as the demand generated by them influences the market growth considerably.

Segmentation by drug class and analysis of the acne drugs market
- Antibiotics
- Anti-inflammatory drugs
- Antimicrobial
- Combination medications
- Hormonal agents
- Oral retinoid
Topical retinoid

Acne medication depends on the skin type and the severity of the condition. For instance, oral retinoid agents are considered as the appropriate treatment for severe acne. These drugs help prevent excessive oil production, bacterial acne growth, and inflammation.

Segmentation by method of administration and analysis of the acne drugs market
- Topical
- Oral

The topical drugs segment dominated the market during 2015, accounting for a market share of around 54%. Ease of application, low systemic side-effects, and easy availability of these products are the primary drivers for the growth of this segment.

Segmentation by type and analysis of the acne drugs market
- Prescription drugs
- OTC drugs

Prescription drugs dominated the market during 2015 due to the increased awareness about acne and the treatments options, especially in the developed countries. For instance, Epiduo, Benzaclin, and Duac are some of the popular acne prescription drugs available in the market.

Segmentation by geography and analysis of the acne drugs market
- Americas
- APAC
- EMEA

The Americas accounted for around 90% of the market share during 2015 but is expected to witness a decline in sales during the forecast period. Lifestyle changes, increase in awareness programs about acne, and availability of acne treatment options are the primary drivers for market growth in this region.

The global acne drugs market is dominated by key vendors. The availability of OTC drugs and the preference for alternative therapies for treating acne has been restricting the sales of branded acne products. Vendors in this market are anticipated to invest heavily on R&D during the forecast period.

The leading vendors in the market are –
- Allergan
- Galderma
- Stiefel
- Valeant

The other prominent vendors in the market include AndroScience, Anterios, Aqua Pharmaceuticals, Astellas, Bayer HealthCare, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, COSMO Pharmaceuticals, Dermira, Elorac, F.Hoffmann-La Roche, Foamix, GlaxoSmithKline, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Johnson & Johnson, Meda, Mylan, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Promius Pharma, Ranbaxy, Reckitt Benckiser, Skinvisible Pharmaceuticals, Teva, Versapharm, and XBiotech.

Key questions answered in the report include
- What will the market size and the growth rate be in 2020
- What are the key factors driving the global acne drugs market
- What are the key market trends impacting the growth of the acne drugs market
- What are the challenges to market growth
- Who are the key vendors in this market space
- What are the market opportunities and threats faced by the vendors in the global acne drugs market
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA
- What are the key outcomes of the five forces analysis of the acne drugs market

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Acne: An overview
Understanding the disease
Pathophysiology
Causes
Types of acne
Implications of acne
Management
Epidemiology

PART 06: Pipeline analysis
Sarecycline
IDP-121
CB-03-01
IDP-120
CB-06-04
ASC-J9
Visonac
DRM-01
FMX101
True human antibody RA-18C3
SB204
Acebilustat
ANT-1207

PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 08: Reimbursement scenario for acne drugs

PART 09: Market segmentation by drug class
Antibiotics
Anti-inflammatory drugs
Antimicrobials
Combination drugs
Hormonal agents
Oral retinoids
Topical retinoids

PART 10: Market segmentation by route of administration
Topical
Oral

PART 11: Market segmentation by type
Prescription drugs
OTC drugs

PART 12: Global acne drugs market: OTC drugs
Major acne OTC products
Adverse effects of OTC acne drugs
Major vendors of OTC acne drugs
OTC acne drugs market in Europe

PART 13: Geographical segmentation
Acne drugs market in Americas
Global acne drugs market in EMEA
Acne drugs market in APAC

PART 14: Market drivers
Prevalence of acne
Lifestyle changes
Significant unmet medical needs
Promising drug pipeline
Rise in disposable income

PART 15: Impact of drivers

PART 16: Market challenges
Adverse effects of drugs
Poor patient adherence
Preference for alternative therapies
Intense market competition

PART 17: Impact of drivers and challenges

PART 18: Market trends
Preference for combination therapies
Acne awareness programs
Product innovations
Increased use of OTC products over prescription drugs
Marketing of OTC acne products

PART 19: Vendor landscape
Competitive scenario
Market share analysis 2015
Valeant Pharmaceuticals
Galderma
Allergan
Stiefel Laboratories
Other prominent vendors

PART 20: Appendix
List of abbreviations

PART 21: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Acne drugs: Key buying criteria
Exhibit 03: Types of acne based on severity
Exhibit 04: Types of acne based on severity of inflammation
Exhibit 05: Implications of acne
Exhibit 06: Treatment algorithm: Management of acne
Exhibit 07: Acne drugs: Pipeline portfolio
Exhibit 08: Global acne drugs market 2015-2020 ($ millions)
Exhibit 09: Five forces analysis
Exhibit 10: Oral prescription acne drugs: Reimbursement by payers in US 2014
Exhibit 11: Topical prescription acne drugs: Reimbursement by payers in US 2014
Exhibit 12: Global acne drugs market segmentation by drug class
Exhibit 13: Global acne drugs market segmentation by route of administration
Exhibit 14: Global acne drugs market segmentation by route of administration 2015
Exhibit 15: Revenue of topical prescription drugs in US 2015
Exhibit 16: Revenue of oral prescription drugs in US 2015
Exhibit 17: Global acne drugs market segmentation by type
Exhibit 18: Global acne drugs market segmentation by type 2015
Exhibit 19: OTC drugs: Advantages and disadvantages
Exhibit 20: AcneFree by Valeant Pharmaceuticals: SWOT analysis
Exhibit 21: Clearasil by Reckitt Benckiser: SWOT analysis
Exhibit 22: Clean & Clear by Johnson & Johnson: SWOT analysis
Exhibit 23: Neutrogena by Johnson & Johnson: SWOT analysis
Exhibit 24: Proactiv by Guthy-Renker: SWOT analysis
Exhibit 25: Global acne drugs market segmentation by geography 2015
Exhibit 26: Global acne drugs market segmentation by geography 2015-2020 ($ millions)
Exhibit 27: Acne drugs market in Americas 2015-2020 ($ millions)
Exhibit 28: Acne drugs market in US 2015-2020 ($ millions)
Exhibit 29: Acne drugs market in EMEA 2015-2020 ($ millions)
Exhibit 30: Acne drugs market in APAC 2015-2020 ($ millions)
Exhibit 31: Impact of drivers
Exhibit 32: Impact of drivers and challenges
Exhibit 33: Ranking of leading vendors 2015
Exhibit 34: Valeant Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 35: Valeant Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 36: Valeant Pharmaceuticals: Product segmentation by revenue 2014
Exhibit 37: Valeant Pharmaceuticals: Geographical segmentation by revenue 2014
Exhibit 38: Valeant Pharmaceuticals: SWOT analysis
Exhibit 39: Galderma: Therapeutic categories
Exhibit 40: Galderma: SWOT analysis
Exhibit 41: Allergan: Business segmentation by product revenue 2014
Exhibit 42: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 43: Allergan: Geographical segmentation by revenue 2014
Exhibit 44: Allergan: SWOT analysis
Exhibit 45: Stiefel Laboratories: Product categories
Exhibit 46: Stiefel Laboratories: SWOT analysis



【掲載企業】

Allergan, Galderma, Stiefel, Valeant, AndroScience, Anterios, Aqua Pharmaceuticals, Astellas, Bayer HealthCare, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, COSMO Pharmaceuticals, Dermira, Elorac, F.Hoffmann-La Roche, Foamix, GlaxoSmithKline, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Johnson & Johnson, Meda, Mylan, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Promius Pharma, Ranbaxy, Reckitt Benckiser, Skinvisible Pharmaceuticals, Teva, Versapharm, XBiotech.


【資料のキーワード】

ニキビ治療薬、座瘡、治療、医薬品、パイプライン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[ニキビ治療薬の世界市場2016-2020] (Global Acne Drugs Market 2016-2020 / IRTNTR7887)販売に関する免責事項
[ニキビ治療薬の世界市場2016-2020] (Global Acne Drugs Market 2016-2020 / IRTNTR7887)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆